Helfie AI Bolsters Operational and Strategic Growth With Appointment of Two Influential Industry Leaders to Executive Team
31.7.2025 14:00:00 CEST | Business Wire | Press Release
Helfie AI, aglobal mobile health platform, today announced the appointment of two new members of the executive leadership team, Stefan Kulik as Chief Operating Officer and Rania Awad as Chief Strategy Officer.
Helfie AI is building the world’s first human health platform, powered by artificial intelligence, to enable anyone with a smartphone anywhere in the world access to easy, instant and affordable health checks. The additions of Mr. Kulik and Ms. Awad to the leadership team strengthens Helfie AI’s capacity to deliver an AI solution to healthcare that emphasizes data ownership, universal access and freedom of choice, enabling early disease detection and prevention on a global scale.
Helfie AI co-founder and CEO George Tomeski said: “The expansion of our leadership team to include Stefan and Rania is a pivotal moment in Helfie’s growth. As we reach across communities worldwide and deliver on our vision of providing an accurate and cost-effective way for patients to obtain health checks, we will rely on their expertise to realize this mission. I look forward to working with them as we continue to develop our Human Health Network platform to bring it to all 8 billion humans worldwide.”
Kulik has over 15 years of experience serving in executive roles at recognizable companies such as PepsiCo, Johnson & Johnson, and Royal Mail. In each of these leadership roles he developed deep expertise in operational excellence and business development. Kulik also has significant experience in private equity and venture capital environments, with specialized knowledge in predictive analytics and artificial intelligence applications. His unique combination of corporate leadership experience and insights gained from working with elite athletes in performance optimization and behavioural change positions him well to drive Helfie AI's continued growth and strategic objectives.
Awad is an accomplished digital strategist and innovator with extensive experience as a licensed pharmacist and business leader. She brings a proven track record of scaling organizations, spearheading digital transformation initiatives, and developing comprehensive product and go-to-market strategies. Her cross-industry expertise spans healthcare, asset management, retail and information technology sectors, with demonstrated success across the Asia-Pacific region, including Australia, New Zealand, and China. Awad's unique combination of pharmaceutical expertise and strategic business acumen positions her to drive Helfie's strategic vision and market expansion objectives.
“Helfie AI is revolutionising the healthcare field by providing consumers with a cost-effective and accurate AI-powered platform, so I look forward to applying my organisational expertise to help achieve this vision on a global scale,” said Kulik. “As we expand Helfie AI’s global growth strategy within the UK, broader international markets, and the US, I will work with my colleagues to bring this critical technology to those who need it most.”
“Helfie AI’s technology aims to bring equitable health access globally to bypass complicated healthcare systems and put AI-powered mobile health checks into individual hands,” said Awad. "In the near-term, I will use my expertise in strategic marketing to help Helfie AI achieve its next stage of growth, which includes a consumer launch and expanded partnerships with organizations and governments worldwide. I’m confident that the expanded leadership team will deliver on Helfie AI’s mission to become the most trusted AI health company in the market.”
Helfie AI's advanced AI technologies analyse pictures, videos, sound recordings or face scans to check for indications of potential health conditions. Helfie AI generates instant results and offers the user information and options on what to do next. Importantly, the user owns and controls all of the data provided as part of the checks.
About Helfie AI
Helfie AI was founded in Melbourne, Australia in 2021 and has expanded operations to Europe, North America, Africa and Asia with multiple active B2B partnerships with top tier companies already in place.
Helfie AI tackles two of healthcare’s most fundamental challenges: the lack of participation in preventative healthcare and the under-utilisation of health data. Every facet of healthcare, starting with the quality and longevity of human life, can be dramatically improved if everyone actively participates in preventative health and if health data is actively utilized throughout the healthcare system.
The accessibility made possible by Helfie AI can significantly reduce the $7 trillion spent annually on treating preventable conditions.
Helfie AI provides users with clear next steps, connects them to medical care if/as required, allows interaction around numerous health conditions, from cardiovascular to skin health, and enables sharing AI findings with their own carers and doctors.
More details on the checks Helfie can make are available at www.helfie.ai
View source version on businesswire.com: https://www.businesswire.com/news/home/20250731802386/en/
Contacts
Media Contacts:
Chris Welsh, ICR Healthcare Europe
Alexis Feinberg, ICR Healthcare US
Helfie@ICRHealthcare.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
South African Agency Boundless Delivers Mazda’s First AI-produced Commercial Using Luma Agents15.4.2026 21:07:00 CEST | Press Release
Luma AI today announced that Boundless, an independent creative agency based in Johannesburg, South Africa, has produced Mazda’s first AI-produced commercial using Luma Agents, Luma’s AI-powered creative workflow system. Delivered in less than two weeks from initial brief to final approval, the project marks a significant step in the use of AI-native workflows for commercial production. As part of the collaboration, Boundless has also signed an agreement with Luma to integrate the company’s AI technologies into its creative workflow across future client work. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260415098939/en/ The project marks a milestone for both Boundless and the broader advertising industry, demonstrating how AI-native workflows can help agencies compress production timelines while maintaining creative quality, brand consistency, and operational oversight. The campaign supports the re-entry of the Mazda MX-5
Chaired by HRH Crown Prince, PIF Board of Directors Approves PIF 2026-2030 Strategy15.4.2026 17:29:00 CEST | Press Release
The Board of Directors ofPIF, chaired by His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince, Prime Minister and Chairman of the Board of Directors of PIF, has approved PIF’s 2026-2030 strategy, which is a continuation of PIF’s long-term strategy. The strategy will focus on delivering competitive domestic ecosystems to connect sectors, unlock the full potential of strategic assets, maximize long-term returns, and continue to drive the economic transformation of Saudi Arabia and further enhance the quality of life of its citizens. The 2026-2030 strategy marks a natural evolution as PIF moves from a period of rapid growth and acceleration to a new phase of sustained value creation, with a strengthened focus on maximizing impact, raising the efficiency of investments, and applying the highest standards of governance, transparency and institutional excellence. In addition, PIF will further enable the role of the private sector as an effective partner for susta
Chaired by HRH Crown Prince, PIF Board of Directors Approves PIF 2026-2030 Strategy15.4.2026 17:29:00 CEST | Press Release
The Board of Directors ofPIF, chaired by His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince, Prime Minister and Chairman of the Board of Directors of PIF, has approved PIF’s 2026-2030 strategy, which is a continuation of PIF’s long-term strategy. The strategy will focus on delivering competitive domestic ecosystems to connect sectors, unlock the full potential of strategic assets, maximize long-term returns, and continue to drive the economic transformation of Saudi Arabia and further enhance the quality of life of its citizens. The 2026-2030 strategy marks a natural evolution as PIF moves from a period of rapid growth and acceleration to a new phase of sustained value creation, with a strengthened focus on maximizing impact, raising the efficiency of investments, and applying the highest standards of governance, transparency and institutional excellence. In addition, PIF will further enable the role of the private sector as an effective partner for susta
New Method Enables Structural Determination of Diverse Phenolic Compounds from a Tiny Alpine Flower Sample15.4.2026 16:00:00 CEST | Press Release
Hyuga Hirano (United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology, and collaborative graduate student at the National Museum of Nature and Science (President: Makoto Manabe)); Takashi Kikuchi (Application Laboratories, Global Product Unit, Rigaku Corporation, a group company of Rigaku Holdings); Futa Sakakibara (Technical Advisor, R&D Support Division, Asterism G.K.); Yoshinori Murai (Senior curator, Department of Botany, National Museum of Nature and Science); and colleagues have successfully determined the structures of more than ten phenolic glycosides from a tiny sample of an alpine plant flower by developing a trace analysis method. This achievement is particularly significant because alpine plants are typically small and difficult to collect due to legal, ethical, and environmental considerations, resulting in extremely limited sample availability. Determining the structures of numerous chemical components from such a small sample repres
New Method Enables Structural Determination of Diverse Phenolic Compounds from a Tiny Alpine Flower Sample15.4.2026 16:00:00 CEST | Press Release
Hyuga Hirano (United Graduate School of Agricultural Science, Tokyo University of Agriculture and Technology, and collaborative graduate student at the National Museum of Nature and Science (President: Makoto Manabe)); Takashi Kikuchi (Application Laboratories, Global Product Unit, Rigaku Corporation, a group company of Rigaku Holdings); Futa Sakakibara (Technical Advisor, R&D Support Division, Asterism G.K.); Yoshinori Murai (Senior curator, Department of Botany, National Museum of Nature and Science); and colleagues have successfully determined the structures of more than ten phenolic glycosides from a tiny sample of an alpine plant flower by developing a trace analysis method. This achievement is particularly significant because alpine plants are typically small and difficult to collect due to legal, ethical, and environmental considerations, resulting in extremely limited sample availability. Determining the structures of numerous chemical components from such a small sample repres
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom